RNA Interference (RNAi) Nucleic Acid Therapeutics Market Size, Opportunities, Key Drivers and Competitive Outlook
RNA Interference (RNAi) Nucleic Acid Therapeutics Market Segmentation, By Type (Small Interfering RNA (siRNA), MicroRNA (miRNA)), Route of Administration (Intravenous, Intradermal, Pulmonary Delivery, Intrathecal, and Others), Indication (Acute Hepatic Porphyria (AHP), Hereditary Transthyretin-Mediated Amyloidosis (hATTR), Hypercholesterolemia, and Others), End User (Hospitals &...
0 Commenti 0 condivisioni 26 Views